CRT 2024
Symposium
POWER BREAK SYMPOSIUM – Valve Performance and Durability in TAVR: Challenges and Innovations [Non-CME] – Sponsored by Medtronic
Stanley J. Chetcuti, MD
Co-Director Structural Heart Program/ Director Cardiac Catheterization Laboratory
University of Michigan
Ann Arbor , Michigan, United States
Disclosure(s): Abbott Vascular: Advisor or Review Panel Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing); BSCI: Advisor (Ongoing), Clinical Trial Investigator (Ongoing); Edwards Lifesciences LLC: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing); MDT: Advisor (Ongoing), Advisor or Review Panel Member (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant/Advisory Board (Ongoing)
Basel Ramlawi, MD
Chief of Cardiac Surgery / Co-Director, Lankenau Heart Institute
Lankenau Heart Institute
Villanova, Pennsylvania, United States
No relationships to disclose
Michael J. Reardon, MD
Professor and Allison Family Distinguished Chair of Cardiovascular Research
Houston Methodist DeBakey Heart & Vascular Center
Houston, Texas, United States
Disclosure information not submitted.
Toby Rogers, MD, PhD
Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
Georgetown University and MedStar Washington Hospital Center
Washington, District of Columbia, United States
Disclosure information not submitted.